[1]
2026. LOW-DOSE VERSUS STANDARD-DOSE RITUXIMAB IN VESICULOBULLOUS DISORDERS: A COMPARATIVE EFFECTIVENESS STUDY. Asian Journal of Medical Research and Health Sciences. 4, 2 (Jul. 2026), 1638–1642. DOI:https://doi.org/10.65605/a-jmrhs.2026.v04.i02.pp1638-1642.